The E3 ubiquitin ligase Peli1 regulates the metabolic actions of mTORC1 to suppress antitumor T cell responses

Metabolic fitness of T cells is crucial for immune responses against infections and tumorigenesis. Both the T cell receptor (TCR) signal and environmental cues contribute to the induction of T cell metabolic reprogramming, but the underlying mechanism is incompletely understood. Here, we identified...

Full description

Saved in:
Bibliographic Details
Published inThe EMBO journal Vol. 40; no. 2; pp. e104532 - n/a
Main Authors Ko, Chun‐Jung, Zhang, Lingyun, Jie, Zuliang, Zhu, Lele, Zhou, Xiaofei, Xie, Xiaoping, Gao, Tianxiao, Yang, Jin‐Young, Cheng, Xuhong, Sun, Shao‐Cong
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 15.01.2021
Springer Nature B.V
John Wiley and Sons Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Metabolic fitness of T cells is crucial for immune responses against infections and tumorigenesis. Both the T cell receptor (TCR) signal and environmental cues contribute to the induction of T cell metabolic reprogramming, but the underlying mechanism is incompletely understood. Here, we identified the E3 ubiquitin ligase Peli1 as an important regulator of T cell metabolism and antitumor immunity. Peli1 ablation profoundly promotes tumor rejection, associated with increased tumor‐infiltrating CD4 and CD8 T cells. The Peli1‐deficient T cells display markedly stronger metabolic activities, particularly glycolysis, than wild‐type T cells. Peli1 controls the activation of a metabolic kinase, mTORC1, stimulated by both the TCR signal and growth factors, and this function of Peli1 is mediated through regulation of the mTORC1‐inhibitory proteins, TSC1 and TSC2. Peli1 mediates non‐degradative ubiquitination of TSC1, thereby promoting TSC1‐TSC2 dimerization and TSC2 stabilization. These results establish Peli1 as a novel regulator of mTORC1 and downstream mTORC1‐mediated actions on T cell metabolism and antitumor immunity. Synopsis The mTORC1 signaling pathway mediates metabolic reprograming and effector function of activated T cells, which is important for antitumor immunity. TSC1 ubiquitination by E3 ubiquitin ligase Peli1 negatively regulates mTORC1 activation and controls glycolytic metabolism and antitumor effector function of T cells. Peli1 negatively regulates activation of the metabolic kinase mTORC1. Peli1 mediates K63 ubiquitination of mTORC1‐inhibitory protein TSC1 and promotes TSC1/TSC2 complex stability. Peli1 deletion promotes the metabolic activities of T cells. Peli1 deficiency in mice promotes antitumor immunity. Graphical Abstract K63‐linked ubiquitination of TSC1 by the Peli E3 inhibits mTORC1 signaling and metabolic reprogramming of T cells.
AbstractList Metabolic fitness of T cells is crucial for immune responses against infections and tumorigenesis. Both the T cell receptor (TCR) signal and environmental cues contribute to the induction of T cell metabolic reprogramming, but the underlying mechanism is incompletely understood. Here, we identified the E3 ubiquitin ligase Peli1 as an important regulator of T cell metabolism and antitumor immunity. Peli1 ablation profoundly promotes tumor rejection, associated with increased tumor‐infiltrating CD4 and CD8 T cells. The Peli1‐deficient T cells display markedly stronger metabolic activities, particularly glycolysis, than wild‐type T cells. Peli1 controls the activation of a metabolic kinase, mTORC1, stimulated by both the TCR signal and growth factors, and this function of Peli1 is mediated through regulation of the mTORC1‐inhibitory proteins, TSC1 and TSC2. Peli1 mediates non‐degradative ubiquitination of TSC1, thereby promoting TSC1‐TSC2 dimerization and TSC2 stabilization. These results establish Peli1 as a novel regulator of mTORC1 and downstream mTORC1‐mediated actions on T cell metabolism and antitumor immunity. Synopsis The mTORC1 signaling pathway mediates metabolic reprograming and effector function of activated T cells, which is important for antitumor immunity. TSC1 ubiquitination by E3 ubiquitin ligase Peli1 negatively regulates mTORC1 activation and controls glycolytic metabolism and antitumor effector function of T cells. Peli1 negatively regulates activation of the metabolic kinase mTORC1. Peli1 mediates K63 ubiquitination of mTORC1‐inhibitory protein TSC1 and promotes TSC1/TSC2 complex stability. Peli1 deletion promotes the metabolic activities of T cells. Peli1 deficiency in mice promotes antitumor immunity. K63‐linked ubiquitination of TSC1 by the Peli E3 inhibits mTORC1 signaling and metabolic reprogramming of T cells.
Metabolic fitness of T cells is crucial for immune responses against infections and tumorigenesis. Both the T cell receptor (TCR) signal and environmental cues contribute to the induction of T cell metabolic reprogramming, but the underlying mechanism is incompletely understood. Here, we identified the E3 ubiquitin ligase Peli1 as an important regulator of T cell metabolism and antitumor immunity. Peli1 ablation profoundly promotes tumor rejection, associated with increased tumor-infiltrating CD4 and CD8 T cells. The Peli1-deficient T cells display markedly stronger metabolic activities, particularly glycolysis, than wild-type T cells. Peli1 controls the activation of a metabolic kinase, mTORC1, stimulated by both the TCR signal and growth factors, and this function of Peli1 is mediated through regulation of the mTORC1-inhibitory proteins, TSC1 and TSC2. Peli1 mediates non-degradative ubiquitination of TSC1, thereby promoting TSC1-TSC2 dimerization and TSC2 stabilization. These results establish Peli1 as a novel regulator of mTORC1 and downstream mTORC1-mediated actions on T cell metabolism and antitumor immunity.
Metabolic fitness of T cells is crucial for immune responses against infections and tumorigenesis. Both the T cell receptor (TCR) signal and environmental cues contribute to the induction of T cell metabolic reprogramming, but the underlying mechanism is incompletely understood. Here, we identified the E3 ubiquitin ligase Peli1 as an important regulator of T cell metabolism and antitumor immunity. Peli1 ablation profoundly promotes tumor rejection, associated with increased tumor-infiltrating CD4 and CD8 T cells. The Peli1-deficient T cells display markedly stronger metabolic activities, particularly glycolysis, than wild-type T cells. Peli1 controls the activation of a metabolic kinase, mTORC1, stimulated by both the TCR signal and growth factors, and this function of Peli1 is mediated through regulation of the mTORC1-inhibitory proteins, TSC1 and TSC2. Peli1 mediates non-degradative ubiquitination of TSC1, thereby promoting TSC1-TSC2 dimerization and TSC2 stabilization. These results establish Peli1 as a novel regulator of mTORC1 and downstream mTORC1-mediated actions on T cell metabolism and antitumor immunity.Metabolic fitness of T cells is crucial for immune responses against infections and tumorigenesis. Both the T cell receptor (TCR) signal and environmental cues contribute to the induction of T cell metabolic reprogramming, but the underlying mechanism is incompletely understood. Here, we identified the E3 ubiquitin ligase Peli1 as an important regulator of T cell metabolism and antitumor immunity. Peli1 ablation profoundly promotes tumor rejection, associated with increased tumor-infiltrating CD4 and CD8 T cells. The Peli1-deficient T cells display markedly stronger metabolic activities, particularly glycolysis, than wild-type T cells. Peli1 controls the activation of a metabolic kinase, mTORC1, stimulated by both the TCR signal and growth factors, and this function of Peli1 is mediated through regulation of the mTORC1-inhibitory proteins, TSC1 and TSC2. Peli1 mediates non-degradative ubiquitination of TSC1, thereby promoting TSC1-TSC2 dimerization and TSC2 stabilization. These results establish Peli1 as a novel regulator of mTORC1 and downstream mTORC1-mediated actions on T cell metabolism and antitumor immunity.
Metabolic fitness of T cells is crucial for immune responses against infections and tumorigenesis. Both the T cell receptor (TCR) signal and environmental cues contribute to the induction of T cell metabolic reprogramming, but the underlying mechanism is incompletely understood. Here, we identified the E3 ubiquitin ligase Peli1 as an important regulator of T cell metabolism and antitumor immunity. Peli1 ablation profoundly promotes tumor rejection, associated with increased tumor‐infiltrating CD4 and CD8 T cells. The Peli1‐deficient T cells display markedly stronger metabolic activities, particularly glycolysis, than wild‐type T cells. Peli1 controls the activation of a metabolic kinase, mTORC1, stimulated by both the TCR signal and growth factors, and this function of Peli1 is mediated through regulation of the mTORC1‐inhibitory proteins, TSC1 and TSC2. Peli1 mediates non‐degradative ubiquitination of TSC1, thereby promoting TSC1‐TSC2 dimerization and TSC2 stabilization. These results establish Peli1 as a novel regulator of mTORC1 and downstream mTORC1‐mediated actions on T cell metabolism and antitumor immunity. Synopsis The mTORC1 signaling pathway mediates metabolic reprograming and effector function of activated T cells, which is important for antitumor immunity. TSC1 ubiquitination by E3 ubiquitin ligase Peli1 negatively regulates mTORC1 activation and controls glycolytic metabolism and antitumor effector function of T cells. Peli1 negatively regulates activation of the metabolic kinase mTORC1. Peli1 mediates K63 ubiquitination of mTORC1‐inhibitory protein TSC1 and promotes TSC1/TSC2 complex stability. Peli1 deletion promotes the metabolic activities of T cells. Peli1 deficiency in mice promotes antitumor immunity. Graphical Abstract K63‐linked ubiquitination of TSC1 by the Peli E3 inhibits mTORC1 signaling and metabolic reprogramming of T cells.
Metabolic fitness of T cells is crucial for immune responses against infections and tumorigenesis. Both the T cell receptor (TCR) signal and environmental cues contribute to the induction of T cell metabolic reprogramming, but the underlying mechanism is incompletely understood. Here, we identified the E3 ubiquitin ligase Peli1 as an important regulator of T cell metabolism and antitumor immunity. Peli1 ablation profoundly promotes tumor rejection, associated with increased tumor‐infiltrating CD4 and CD8 T cells. The Peli1‐deficient T cells display markedly stronger metabolic activities, particularly glycolysis, than wild‐type T cells. Peli1 controls the activation of a metabolic kinase, mTORC1, stimulated by both the TCR signal and growth factors, and this function of Peli1 is mediated through regulation of the mTORC1‐inhibitory proteins, TSC1 and TSC2. Peli1 mediates non‐degradative ubiquitination of TSC1, thereby promoting TSC1‐TSC2 dimerization and TSC2 stabilization. These results establish Peli1 as a novel regulator of mTORC1 and downstream mTORC1‐mediated actions on T cell metabolism and antitumor immunity. K63‐linked ubiquitination of TSC1 by the Peli E3 inhibits mTORC1 signaling and metabolic reprogramming of T cells.
Author Gao, Tianxiao
Ko, Chun‐Jung
Xie, Xiaoping
Zhu, Lele
Yang, Jin‐Young
Cheng, Xuhong
Zhou, Xiaofei
Jie, Zuliang
Sun, Shao‐Cong
Zhang, Lingyun
AuthorAffiliation 2 Center for Reproductive Medicine Henan Key Laboratory of Reproduction and Genetics The First Affiliated Hospital of Zhengzhou University Zhengzhou China
4 MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences Houston TX USA
1 Department of Immunology The University of Texas MD Anderson Cancer Center Houston TX USA
3 Department of Biological Sciences Pusan National University Busan South Korea
AuthorAffiliation_xml – name: 4 MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences Houston TX USA
– name: 1 Department of Immunology The University of Texas MD Anderson Cancer Center Houston TX USA
– name: 3 Department of Biological Sciences Pusan National University Busan South Korea
– name: 2 Center for Reproductive Medicine Henan Key Laboratory of Reproduction and Genetics The First Affiliated Hospital of Zhengzhou University Zhengzhou China
Author_xml – sequence: 1
  givenname: Chun‐Jung
  orcidid: 0000-0001-6565-7060
  surname: Ko
  fullname: Ko, Chun‐Jung
  organization: Department of Immunology, The University of Texas MD Anderson Cancer Center
– sequence: 2
  givenname: Lingyun
  surname: Zhang
  fullname: Zhang, Lingyun
  organization: Department of Immunology, The University of Texas MD Anderson Cancer Center, Center for Reproductive Medicine, Henan Key Laboratory of Reproduction and Genetics, The First Affiliated Hospital of Zhengzhou University
– sequence: 3
  givenname: Zuliang
  surname: Jie
  fullname: Jie, Zuliang
  organization: Department of Immunology, The University of Texas MD Anderson Cancer Center
– sequence: 4
  givenname: Lele
  surname: Zhu
  fullname: Zhu, Lele
  organization: Department of Immunology, The University of Texas MD Anderson Cancer Center
– sequence: 5
  givenname: Xiaofei
  surname: Zhou
  fullname: Zhou, Xiaofei
  organization: Department of Immunology, The University of Texas MD Anderson Cancer Center
– sequence: 6
  givenname: Xiaoping
  orcidid: 0000-0001-6616-1059
  surname: Xie
  fullname: Xie, Xiaoping
  organization: Department of Immunology, The University of Texas MD Anderson Cancer Center
– sequence: 7
  givenname: Tianxiao
  surname: Gao
  fullname: Gao, Tianxiao
  organization: Department of Immunology, The University of Texas MD Anderson Cancer Center
– sequence: 8
  givenname: Jin‐Young
  surname: Yang
  fullname: Yang, Jin‐Young
  organization: Department of Immunology, The University of Texas MD Anderson Cancer Center, Department of Biological Sciences, Pusan National University
– sequence: 9
  givenname: Xuhong
  surname: Cheng
  fullname: Cheng, Xuhong
  organization: Department of Immunology, The University of Texas MD Anderson Cancer Center
– sequence: 10
  givenname: Shao‐Cong
  surname: Sun
  fullname: Sun, Shao‐Cong
  email: ssun@mdanderson.org
  organization: Department of Immunology, The University of Texas MD Anderson Cancer Center, MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33215753$$D View this record in MEDLINE/PubMed
BookMark eNqFkc9vFCEYhompsdvq3ZMh8eJlKjDDDJMYE92sv1JTY9YzYWY-tmwYmAJj0_--rNta20Q9ceB5Xr6P9wgdOO8AoeeUnFDOOHsNY7c9YYQRSipeskdoQauaFIw0_AAtCKtpUVHRHqKjGLeEEC4a-gQdliWjvOHlArn1OeBViefOXMwmGYet2agI-BtYQ3GAzWxVgohT5kZIqvPW9Fj1yXgXsdd4XJ99X1KcPI7zNAWIESuXTJpHH_Aa92BtjolTxiE-RY-1shGe3ZzH6MeH1Xr5qTg9-_h5-e606DltWdGC0KViFR_ooAWjjFPViF6zTg0dkFoPXaloT2vdacZ6TYQQNQwZI0JXdVkeo7f73GnuRhh6cCkoK6dgRhWupFdG3r9x5lxu_E_ZCNI2hOWAVzcBwV_MEJMcTdztohz4OUqWXyFtK6od-vIBuvVzcHm9TDWNyBTjmXrx50S_R7mtIgP1HuiDjzGAlr1JavfNeUBjJSXyV-dy17m86zyL5IF4m_0P5c1euTQWrv7Ly9XX91_u6XSvx2y6DYS7jf_65DWbsNC4
CitedBy_id crossref_primary_10_1186_s12967_021_03226_1
crossref_primary_10_3390_ijms24098441
crossref_primary_10_1038_s41419_024_06470_7
crossref_primary_10_1016_j_yjmcc_2022_09_004
crossref_primary_10_1136_jitc_2022_005845
crossref_primary_10_1016_j_celrep_2021_109904
crossref_primary_10_3389_fimmu_2023_1292022
crossref_primary_10_1016_j_clim_2023_109736
crossref_primary_10_1038_s41467_025_56440_6
crossref_primary_10_1155_2021_2982924
crossref_primary_10_1186_s40164_024_00552_0
crossref_primary_10_1016_j_cellsig_2024_111194
crossref_primary_10_1016_j_jsbmb_2022_106120
crossref_primary_10_1038_s41419_023_05937_3
crossref_primary_10_4049_jimmunol_2100236
crossref_primary_10_1186_s13046_024_03008_9
Cites_doi 10.3389/fimmu.2018.00014
10.1038/ni.2090
10.4049/jimmunol.161.10.5516
10.1016/j.cytogfr.2017.03.004
10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
10.1016/j.it.2008.10.001
10.1038/ni.1777
10.1002/ijc.2910610120
10.1158/2159-8290.CD-17-0952
10.1016/j.celrep.2018.01.040
10.1016/j.cell.2013.05.016
10.1038/s41571-019-0203-7
10.1038/nri3198
10.1038/ncb839
10.1146/annurev-immunol-032712-095956
10.4161/auto.1.2.1697
10.1016/1044-0305(94)80016-2
10.1172/JCI73939
10.1126/science.1242454
10.1038/cmi.2011.60
10.4049/jimmunol.1103143
10.1016/S1097-2765(01)00187-3
10.1016/j.cell.2017.04.004
10.1038/sj.onc.1204009
10.1038/s41586-018-0697-7
10.1084/jem.20062694
10.1038/s41590-019-0405-2
10.1074/jbc.C500451200
10.1002/eji.201141411
10.1101/gad.1599207
10.1158/1078-0432.CCR-17-0894
10.1016/j.smim.2012.12.004
10.1016/j.smim.2016.10.009
10.4161/trns.28263
10.1038/nri3701
10.1146/annurev-cellbio-092910-154237
10.1146/annurev.immunol.021908.132706
10.1042/BJ20080281
10.1038/nri3599
10.1016/j.celrep.2019.03.037
10.1038/nature11866
10.1002/gene.20012
10.1016/j.cell.2018.08.061
10.1002/jms.229
ContentType Journal Article
Copyright The Author(s) 2020
2020 The Authors
2020 The Authors.
2021 EMBO
Copyright_xml – notice: The Author(s) 2020
– notice: 2020 The Authors
– notice: 2020 The Authors.
– notice: 2021 EMBO
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QG
7QL
7QP
7T5
7TK
7TM
7TO
7U9
8FD
C1K
FR3
H94
K9.
M7N
P64
RC3
7X8
5PM
DOI 10.15252/embj.2020104532
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Immunology Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Virology and AIDS Abstracts
Oncogenes and Growth Factors Abstracts
Technology Research Database
Nucleic Acids Abstracts
ProQuest Health & Medical Complete (Alumni)
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
Genetics Abstracts
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
Immunology Abstracts
Engineering Research Database
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
DatabaseTitleList
MEDLINE
Virology and AIDS Abstracts
MEDLINE - Academic


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Biology
DocumentTitleAlternate Chun‐Jung Ko et al
EISSN 1460-2075
EndPage n/a
ExternalDocumentID PMC7809702
33215753
10_15252_embj_2020104532
EMBJ2020104532
Genre article
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: China Scholarship Council
  grantid: 201906380080
  funderid: 10.13039/501100004543
– fundername: MD Anderson Cancer Center
  grantid: P30CA016672
  funderid: 10.13039/100007313
– fundername: National Institutes of Health
  grantid: AI104519; AI64639
  funderid: 10.13039/100000002
– fundername: MD Anderson Cancer Center
  funderid: P30CA016672
– fundername: National Institutes of Health
  funderid: AI104519; AI64639
– fundername: China Scholarship Council
  funderid: 201906380080
– fundername: NCI NIH HHS
  grantid: P30 CA016672
– fundername: NIAID NIH HHS
  grantid: R01 AI104519
– fundername: NIAID NIH HHS
  grantid: R01 AI064639
– fundername: NIAID NIH HHS
  grantid: R37 AI064639
– fundername: China Scholarship Council
  grantid: 201906380080
– fundername: ;
  grantid: AI104519; AI64639
– fundername: ;
  grantid: P30CA016672
– fundername: ;
  grantid: 201906380080
GroupedDBID ---
-DZ
-~X
0R~
123
1OC
24P
29G
2WC
33P
36B
39C
53G
5VS
70F
8R4
8R5
A8Z
AAESR
AAEVG
AAHBH
AAHHS
AAIHA
AAJSJ
AANLZ
AAONW
AAXRX
AAYCA
AAZKR
ABCUV
ABLJU
ACAHQ
ACCFJ
ACCZN
ACGFO
ACGFS
ACNCT
ACPOU
ACPRK
ACXBN
ACXQS
ADBBV
ADEOM
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AENEX
AEQDE
AEUYR
AFBPY
AFFNX
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHMBA
AIAGR
AIURR
AIWBW
AJBDE
ALAGY
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
AOIJS
AUFTA
AZBYB
AZFZN
AZVAB
BAWUL
BDRZF
BENPR
BFHJK
BMNLL
BMXJE
BRXPI
BTFSW
C6C
CS3
DCZOG
DIK
DPXWK
DRFUL
DRSTM
DU5
E3Z
EBD
EBLON
EBS
EMB
EMOBN
F5P
G-S
GROUPED_DOAJ
GX1
HH5
HK~
HYE
KQ8
LATKE
LEEKS
LITHE
LOXES
LUTES
LYRES
MEWTI
MRFUL
MRSTM
MSFUL
MSSTM
MVM
MXFUL
MXSTM
MY~
O9-
OK1
P2P
P2W
Q2X
R.K
RHF
RHI
RNS
ROL
RPM
SV3
TN5
TR2
WBKPD
WH7
WIH
WIK
WIN
WOHZO
WXSBR
WYJ
YSK
ZCA
ZZTAW
~KM
ABJNI
AASML
AAYXX
ABZEH
CITATION
NAO
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7QG
7QL
7QP
7T5
7TK
7TM
7TO
7U9
8FD
C1K
FR3
H94
K9.
M7N
P64
RC3
7X8
5PM
AASGY
ID FETCH-LOGICAL-c5192-9e8f3a245d1df821251a78cf2badbe06fdb3a1c16fbf22cf08886ed25108f4633
IEDL.DBID C6C
ISSN 0261-4189
1460-2075
IngestDate Thu Aug 21 18:22:08 EDT 2025
Fri Jul 11 03:42:57 EDT 2025
Sat Aug 23 12:51:01 EDT 2025
Mon Jul 21 05:57:21 EDT 2025
Tue Jul 01 01:47:22 EDT 2025
Thu Apr 24 23:04:21 EDT 2025
Wed Jan 22 16:58:45 EST 2025
Fri Feb 21 02:37:32 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Peli1
T cell metabolism; antitumor immunity
ubiquitination
mTORC1
Language English
License 2020 The Authors.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5192-9e8f3a245d1df821251a78cf2badbe06fdb3a1c16fbf22cf08886ed25108f4633
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-6616-1059
0000-0001-6565-7060
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/embj.2020104532
PMID 33215753
PQID 2477899825
PQPubID 35985
PageCount 12
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7809702
proquest_miscellaneous_2463099842
proquest_journals_2477899825
pubmed_primary_33215753
crossref_citationtrail_10_15252_embj_2020104532
crossref_primary_10_15252_embj_2020104532
wiley_primary_10_15252_embj_2020104532_EMBJ2020104532
springer_journals_10_15252_embj_2020104532
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 15 January 2021
PublicationDateYYYYMMDD 2021-01-15
PublicationDate_xml – month: 01
  year: 2021
  text: 15 January 2021
  day: 15
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
– name: New York
– name: Hoboken
PublicationTitle The EMBO journal
PublicationTitleAbbrev EMBO J
PublicationTitleAlternate EMBO J
PublicationYear 2021
Publisher Nature Publishing Group UK
Springer Nature B.V
John Wiley and Sons Inc
Publisher_xml – name: Nature Publishing Group UK
– name: Springer Nature B.V
– name: John Wiley and Sons Inc
References Mizushima (CR23) 2007; 21
Cunha, Yang, Carter, Guy, Harris, Crawford, Quarato, Boada‐Romero, Kalkavan, Johnson (CR10) 2018; 175
Yang, Chi (CR42) 2012; 24
Li, Wenes, Romero, Huang, Fendt, Ho (CR19) 2019; 16
Moynagh (CR25) 2014; 14
Moynagh (CR24) 2009; 30
Menk, Scharping, Moreci, Zeng, Guy, Salvatore, Bae, Xie, Young, Wendell (CR22) 2018; 22
Chong‐Kopera, Inoki, Li, Zhu, Garcia‐Gonzalo, Rosa, Guan (CR9) 2006; 281
Chang, Jin, Chang, Xiao, Brittain, Yu, Zhou, Wang, Cheng, Li (CR6) 2011; 12
Smith‐Garvin, Koretzky, Jordan (CR35) 2009; 27
Inoki, Li, Zhu, Wu, Guan (CR16) 2002; 4
Rivadeneira, Delgoffe (CR32) 2018; 24
Chang, Jin, Sun (CR7) 2009; 10
O'Brien, Gorentla, Xie, Srivatsan, McLeod, He, Zhong (CR26) 2011; 41
Durgeau, Virk, Corgnac, Mami‐Chouaib (CR12) 2018; 9
Tanida, Minematsu‐Ikeguchi, Ueno, Kominami (CR36) 2005; 1
Aagaard, Lukas, Bartkova, Kjerulff, Strauss, Bartek (CR1) 1995; 61
Reiley, Jin, Lee, Wright, Wu, Tewalt, Leonard, Norbury, Fitzpatrick, Zhang (CR31) 2007; 204
Peng, Gygi (CR28) 2001; 36
Kim, Guan (CR18) 2015; 125
Testa, Schaft, van der Hoeven, Glaser, Anastassiadis, Zhang, Hermann, Stremmel, Stewart (CR37) 2004; 38
Almeida, Lochner, Berod, Sparwasser (CR2) 2016; 28
Gnanaprakasam, Sherman, Wang (CR14) 2017; 35
Buck, Sowell, Kaech, Pearce (CR4) 2017; 169
Jin, Chang, Sun (CR17) 2012; 9
Wang, Saffold, Cao, Krauss, Chen (CR39) 1998; 161
Pearce, Poffenberger, Chang, Jones (CR27) 2013; 342
Eng, McCormack, Yates (CR13) 1994; 5
Chang, Curtis, Maggi, Faubert, Villarino, O'Sullivan, Huang, van der Windt, Blagih, Qiu (CR5) 2013; 153
Lunt, Vander Heiden (CR20) 2011; 27
DeVorkin, Pavey, Carleton, Comber, Ho, Lim, McNamara, Huang, Kim, Zacharias (CR11) 2019; 27
Shoji‐Kawata, Sumpter, Leveno, Campbell, Zou, Kinch, Wilkins, Sun, Pallauf, MacDuff (CR34) 2013; 494
Pollizzi, Powell (CR30) 2014; 14
Maciver, Michalek, Rathmell (CR21) 2013; 31
Yang, Herter‐Sprie, Zhang, Lin, Biancur, Wang, Deng, Hai, Yang, Wong (CR41) 2018; 8
Zeng, Chi (CR43) 2014; 5
Huang, Manning (CR15) 2008; 412
Benvenuto, Li, Brown, Braverman, Vass, Cheadle, Halley, Sampson, Wienecke, DeClue (CR3) 2000; 19
Poillet‐Perez, Xie, Zhan, Yang, Sharp, Hu, Su, Maganti, Jiang, Lu (CR29) 2018; 563
Zhou, Yu, Cheng, Zhao, Manyam, Zhang, Schluns, Li, Wang, Sun (CR44) 2019; 20
Waickman, Powell (CR38) 2012; 188
Xiao, Harhaj, Sun (CR40) 2001; 7
Chi (CR8) 2012; 12
Shevchenko, Wilm, Vorm, Mann (CR33) 1996; 68
2012; 188
2007; 204
2015; 125
2018; 563
2019; 16
2013; 342
2002; 4
2011; 12
2018; 22
2012; 12
2009; 27
2018; 24
2018; 175
2018; 9
1995; 61
2018; 8
2009; 30
2014; 5
2000; 19
2009; 10
2001; 7
2019; 20
2004; 38
2017; 35
2013; 31
2019; 27
2011; 41
2014; 14
2005; 1
2008; 412
2013; 153
2006; 281
2013; 494
2016; 28
2011; 27
2007; 21
1996; 68
2012; 24
2017; 169
2001; 36
1994; 5
1998; 161
2012; 9
e_1_2_9_30_1
e_1_2_9_31_1
e_1_2_9_11_1
e_1_2_9_34_1
e_1_2_9_10_1
e_1_2_9_35_1
e_1_2_9_13_1
e_1_2_9_32_1
e_1_2_9_12_1
e_1_2_9_33_1
Wang J (e_1_2_9_40_1) 1998; 161
e_1_2_9_15_1
e_1_2_9_38_1
e_1_2_9_14_1
e_1_2_9_39_1
e_1_2_9_17_1
e_1_2_9_36_1
e_1_2_9_16_1
e_1_2_9_37_1
e_1_2_9_19_1
e_1_2_9_18_1
e_1_2_9_41_1
e_1_2_9_42_1
e_1_2_9_20_1
e_1_2_9_22_1
e_1_2_9_45_1
e_1_2_9_21_1
e_1_2_9_24_1
e_1_2_9_43_1
e_1_2_9_23_1
e_1_2_9_44_1
e_1_2_9_8_1
e_1_2_9_7_1
e_1_2_9_6_1
e_1_2_9_5_1
e_1_2_9_4_1
e_1_2_9_3_1
e_1_2_9_2_1
e_1_2_9_9_1
e_1_2_9_26_1
e_1_2_9_25_1
e_1_2_9_28_1
e_1_2_9_27_1
e_1_2_9_29_1
References_xml – volume: 153
  start-page: 1239
  year: 2013
  end-page: 1251
  ident: CR5
  article-title: Posttranscriptional control of T cell effector function by aerobic glycolysis
  publication-title: Cell
– volume: 175
  start-page: 429
  issue: 2
  year: 2018
  end-page: 441.
  ident: CR10
  article-title: LC3‐associated phagocytosis in myeloid cells promotes tumor immune tolerance
  publication-title: Cell
– volume: 28
  start-page: 514
  year: 2016
  end-page: 524
  ident: CR2
  article-title: Metabolic pathways in T cell activation and lineage differentiation
  publication-title: Semin Immunol
– volume: 204
  start-page: 1475
  year: 2007
  end-page: 1485
  ident: CR31
  article-title: Deubiquitinating enzyme CYLD negatively regulates the ubiquitin‐dependent kinase Tak1 and prevents abnormal T cell responses
  publication-title: J Exp Med
– volume: 188
  start-page: 4721
  year: 2012
  end-page: 4729
  ident: CR38
  article-title: Mammalian target of rapamycin integrates diverse inputs to guide the outcome of antigen recognition in T cells
  publication-title: J Immunol
– volume: 19
  start-page: 6306
  year: 2000
  end-page: 6316
  ident: CR3
  article-title: The tuberous sclerosis‐1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination
  publication-title: Oncogene
– volume: 161
  start-page: 5516
  year: 1998
  end-page: 5524
  ident: CR39
  article-title: Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell‐tumor fusion vaccines
  publication-title: J Immunol
– volume: 9
  start-page: 14
  year: 2018
  ident: CR12
  article-title: Recent advances in targeting CD8 T‐cell immunity for more effective cancer immunotherapy
  publication-title: Front Immunol
– volume: 22
  start-page: 1509
  year: 2018
  end-page: 1521
  ident: CR22
  article-title: Early TCR signaling induces rapid aerobic glycolysis enabling distinct acute T cell effector functions
  publication-title: Cell Rep
– volume: 31
  start-page: 259
  year: 2013
  end-page: 283
  ident: CR21
  article-title: Metabolic regulation of T lymphocytes
  publication-title: Annu Rev Immunol
– volume: 21
  start-page: 2861
  year: 2007
  end-page: 2873
  ident: CR23
  article-title: Autophagy: process and function
  publication-title: Genes Dev
– volume: 61
  start-page: 115
  year: 1995
  end-page: 120
  ident: CR1
  article-title: Aberrations of p16Ink4 and retinoblastoma tumour‐suppressor genes occur in distinct sub‐sets of human cancer cell lines
  publication-title: Int J Cancer
– volume: 7
  start-page: 401
  year: 2001
  end-page: 409
  ident: CR40
  article-title: NF‐kappaB‐inducing kinase regulates the processing of NF‐kappaB2 p100
  publication-title: Mol Cell
– volume: 36
  start-page: 1083
  year: 2001
  end-page: 1091
  ident: CR28
  article-title: Proteomics: the move to mixtures
  publication-title: J Mass Spectrom
– volume: 35
  start-page: 63
  year: 2017
  end-page: 70
  ident: CR14
  article-title: MYC and HIF in shaping immune response and immune metabolism
  publication-title: Cytokine Growth Factor Rev
– volume: 12
  start-page: 325
  year: 2012
  end-page: 338
  ident: CR8
  article-title: Regulation and function of mTOR signalling in T cell fate decisions
  publication-title: Nat Rev Immunol
– volume: 27
  start-page: 502
  issue: 2
  year: 2019
  end-page: 513.
  ident: CR11
  article-title: Autophagy regulation of metabolism is required for CD8(+) T cell anti‐tumor immunity
  publication-title: Cell Rep
– volume: 38
  start-page: 151
  year: 2004
  end-page: 158
  ident: CR37
  article-title: A reliable lacZ expression reporter cassette for multipurpose, knockout‐first alleles
  publication-title: Genesis
– volume: 24
  start-page: 2473
  year: 2018
  end-page: 2481
  ident: CR32
  article-title: Antitumor T‐cell reconditioning: improving metabolic fitness for optimal cancer immunotherapy
  publication-title: Clin Cancer Res
– volume: 1
  start-page: 84
  year: 2005
  end-page: 91
  ident: CR36
  article-title: Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy
  publication-title: Autophagy
– volume: 169
  start-page: 570
  year: 2017
  end-page: 586
  ident: CR4
  article-title: Metabolic Instruction of Immunity
  publication-title: Cell
– volume: 563
  start-page: 569
  year: 2018
  end-page: 573
  ident: CR29
  article-title: Autophagy maintains tumour growth through circulating arginine
  publication-title: Nature
– volume: 412
  start-page: 179
  year: 2008
  end-page: 190
  ident: CR15
  article-title: The TSC1‐TSC2 complex: a molecular switchboard controlling cell growth
  publication-title: Biochem J
– volume: 5
  year: 2014
  ident: CR43
  article-title: mTOR signaling and transcriptional regulation in T lymphocytes
  publication-title: Transcription
– volume: 68
  start-page: 850
  year: 1996
  end-page: 858
  ident: CR33
  article-title: Mass spectrometric sequencing of proteins silver‐stained polyacrylamide gels
  publication-title: Anal Chem
– volume: 125
  start-page: 25
  year: 2015
  end-page: 32
  ident: CR18
  article-title: mTOR: a pharmacologic target for autophagy regulation
  publication-title: J Clin Invest
– volume: 20
  start-page: 879
  year: 2019
  end-page: 889
  ident: CR44
  article-title: The deubiquitinase Otub1 controls the activation of CD8(+) T cells and NK cells by regulating IL‐15‐mediated priming
  publication-title: Nat Immunol
– volume: 41
  start-page: 3361
  year: 2011
  end-page: 3370
  ident: CR26
  article-title: Regulation of T‐cell survival and mitochondrial homeostasis by TSC1
  publication-title: Eur J Immunol
– volume: 14
  start-page: 435
  year: 2014
  end-page: 446
  ident: CR30
  article-title: Integrating canonical and metabolic signalling programmes in the regulation of T cell responses
  publication-title: Nat Rev Immunol
– volume: 9
  start-page: 113
  year: 2012
  end-page: 122
  ident: CR17
  article-title: Peli: a family of signal‐responsive E3 ubiquitin ligases mediating TLR signaling and T‐cell tolerance
  publication-title: Cell Mol Immunol
– volume: 27
  start-page: 441
  year: 2011
  end-page: 464
  ident: CR20
  article-title: Aerobic glycolysis: meeting the metabolic requirements of cell proliferation
  publication-title: Annu Rev Cell Dev Biol
– volume: 342
  start-page: 1242454
  year: 2013
  ident: CR27
  article-title: Fueling immunity: insights into metabolism and lymphocyte function
  publication-title: Science
– volume: 10
  start-page: 1089
  year: 2009
  end-page: 1095
  ident: CR7
  article-title: Peli1 facilitates TRIF‐dependent Toll‐like receptor signaling and proinflammatory cytokine production
  publication-title: Nat Immunol
– volume: 27
  start-page: 591
  year: 2009
  end-page: 619
  ident: CR35
  article-title: T cell activation
  publication-title: Annu Rev Immunol
– volume: 8
  start-page: 276
  year: 2018
  end-page: 287
  ident: CR41
  article-title: Autophagy sustains pancreatic cancer growth through both cell‐autonomous and nonautonomous mechanisms
  publication-title: Cancer Discov
– volume: 5
  start-page: 976
  year: 1994
  end-page: 989
  ident: CR13
  article-title: An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database
  publication-title: J Am Soc Mass Spectrom
– volume: 4
  start-page: 648
  year: 2002
  end-page: 657
  ident: CR16
  article-title: TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
  publication-title: Nat Cell Biol
– volume: 12
  start-page: 1002
  year: 2011
  end-page: 1009
  ident: CR6
  article-title: The ubiquitin ligase Peli1 negatively regulates T cell activation and prevents autoimmunity
  publication-title: Nat Immunol
– volume: 494
  start-page: 201
  year: 2013
  end-page: 206
  ident: CR34
  article-title: Identification of a candidate therapeutic autophagy‐inducing peptide
  publication-title: Nature
– volume: 30
  start-page: 33
  year: 2009
  end-page: 42
  ident: CR24
  article-title: The Pellino family: IRAK E3 ligases with emerging roles in innate immune signalling
  publication-title: Trends Immunol
– volume: 281
  start-page: 8313
  year: 2006
  end-page: 8316
  ident: CR9
  article-title: TSC1 stabilizes TSC2 by inhibiting the interaction between TSC2 and the HERC1 ubiquitin ligase
  publication-title: J Biol Chem
– volume: 14
  start-page: 122
  year: 2014
  end-page: 131
  ident: CR25
  article-title: The roles of Pellino E3 ubiquitin ligases in immunity
  publication-title: Nat Rev Immunol
– volume: 16
  start-page: 425
  year: 2019
  end-page: 441
  ident: CR19
  article-title: Navigating metabolic pathways to enhance antitumour immunity and immunotherapy
  publication-title: Nat Rev Clin Oncol
– volume: 24
  start-page: 421
  year: 2012
  end-page: 428
  ident: CR42
  article-title: mTOR and metabolic pathways in T cell quiescence and functional activation
  publication-title: Semin Immunol
– volume: 12
  start-page: 1002
  year: 2011
  end-page: 1009
  article-title: The ubiquitin ligase Peli1 negatively regulates T cell activation and prevents autoimmunity
  publication-title: Nat Immunol
– volume: 9
  start-page: 14
  year: 2018
  article-title: Recent advances in targeting CD8 T‐cell immunity for more effective cancer immunotherapy
  publication-title: Front Immunol
– volume: 20
  start-page: 879
  year: 2019
  end-page: 889
  article-title: The deubiquitinase Otub1 controls the activation of CD8(+) T cells and NK cells by regulating IL‐15‐mediated priming
  publication-title: Nat Immunol
– volume: 494
  start-page: 201
  year: 2013
  end-page: 206
  article-title: Identification of a candidate therapeutic autophagy‐inducing peptide
  publication-title: Nature
– volume: 19
  start-page: 6306
  year: 2000
  end-page: 6316
  article-title: The tuberous sclerosis‐1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination
  publication-title: Oncogene
– volume: 36
  start-page: 1083
  year: 2001
  end-page: 1091
  article-title: Proteomics: the move to mixtures
  publication-title: J Mass Spectrom
– volume: 21
  start-page: 2861
  year: 2007
  end-page: 2873
  article-title: Autophagy: process and function
  publication-title: Genes Dev
– volume: 24
  start-page: 421
  year: 2012
  end-page: 428
  article-title: mTOR and metabolic pathways in T cell quiescence and functional activation
  publication-title: Semin Immunol
– volume: 7
  start-page: 401
  year: 2001
  end-page: 409
  article-title: NF‐kappaB‐inducing kinase regulates the processing of NF‐kappaB2 p100
  publication-title: Mol Cell
– volume: 14
  start-page: 435
  year: 2014
  end-page: 446
  article-title: Integrating canonical and metabolic signalling programmes in the regulation of T cell responses
  publication-title: Nat Rev Immunol
– volume: 28
  start-page: 514
  year: 2016
  end-page: 524
  article-title: Metabolic pathways in T cell activation and lineage differentiation
  publication-title: Semin Immunol
– volume: 175
  start-page: 429
  issue: 2
  year: 2018
  end-page: 441.
  article-title: LC3‐associated phagocytosis in myeloid cells promotes tumor immune tolerance
  publication-title: Cell
– volume: 24
  start-page: 2473
  year: 2018
  end-page: 2481
  article-title: Antitumor T‐cell reconditioning: improving metabolic fitness for optimal cancer immunotherapy
  publication-title: Clin Cancer Res
– volume: 9
  start-page: 113
  year: 2012
  end-page: 122
  article-title: Peli: a family of signal‐responsive E3 ubiquitin ligases mediating TLR signaling and T‐cell tolerance
  publication-title: Cell Mol Immunol
– volume: 22
  start-page: 1509
  year: 2018
  end-page: 1521
  article-title: Early TCR signaling induces rapid aerobic glycolysis enabling distinct acute T cell effector functions
  publication-title: Cell Rep
– volume: 16
  start-page: 425
  year: 2019
  end-page: 441
  article-title: Navigating metabolic pathways to enhance antitumour immunity and immunotherapy
  publication-title: Nat Rev Clin Oncol
– volume: 153
  start-page: 1239
  year: 2013
  end-page: 1251
  article-title: Posttranscriptional control of T cell effector function by aerobic glycolysis
  publication-title: Cell
– volume: 10
  start-page: 1089
  year: 2009
  end-page: 1095
  article-title: Peli1 facilitates TRIF‐dependent Toll‐like receptor signaling and proinflammatory cytokine production
  publication-title: Nat Immunol
– volume: 12
  start-page: 325
  year: 2012
  end-page: 338
  article-title: Regulation and function of mTOR signalling in T cell fate decisions
  publication-title: Nat Rev Immunol
– volume: 125
  start-page: 25
  year: 2015
  end-page: 32
  article-title: mTOR: a pharmacologic target for autophagy regulation
  publication-title: J Clin Invest
– volume: 342
  start-page: 1242454
  year: 2013
  article-title: Fueling immunity: insights into metabolism and lymphocyte function
  publication-title: Science
– volume: 5
  year: 2014
  article-title: mTOR signaling and transcriptional regulation in T lymphocytes
  publication-title: Transcription
– volume: 41
  start-page: 3361
  year: 2011
  end-page: 3370
  article-title: Regulation of T‐cell survival and mitochondrial homeostasis by TSC1
  publication-title: Eur J Immunol
– volume: 38
  start-page: 151
  year: 2004
  end-page: 158
  article-title: A reliable lacZ expression reporter cassette for multipurpose, knockout‐first alleles
  publication-title: Genesis
– volume: 161
  start-page: 5516
  year: 1998
  end-page: 5524
  article-title: Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell‐tumor fusion vaccines
  publication-title: J Immunol
– volume: 204
  start-page: 1475
  year: 2007
  end-page: 1485
  article-title: Deubiquitinating enzyme CYLD negatively regulates the ubiquitin‐dependent kinase Tak1 and prevents abnormal T cell responses
  publication-title: J Exp Med
– volume: 1
  start-page: 84
  year: 2005
  end-page: 91
  article-title: Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy
  publication-title: Autophagy
– volume: 31
  start-page: 259
  year: 2013
  end-page: 283
  article-title: Metabolic regulation of T lymphocytes
  publication-title: Annu Rev Immunol
– volume: 61
  start-page: 115
  year: 1995
  end-page: 120
  article-title: Aberrations of p16Ink4 and retinoblastoma tumour‐suppressor genes occur in distinct sub‐sets of human cancer cell lines
  publication-title: Int J Cancer
– volume: 412
  start-page: 179
  year: 2008
  end-page: 190
  article-title: The TSC1‐TSC2 complex: a molecular switchboard controlling cell growth
  publication-title: Biochem J
– volume: 27
  start-page: 441
  year: 2011
  end-page: 464
  article-title: Aerobic glycolysis: meeting the metabolic requirements of cell proliferation
  publication-title: Annu Rev Cell Dev Biol
– volume: 30
  start-page: 33
  year: 2009
  end-page: 42
  article-title: The Pellino family: IRAK E3 ligases with emerging roles in innate immune signalling
  publication-title: Trends Immunol
– volume: 281
  start-page: 8313
  year: 2006
  end-page: 8316
  article-title: TSC1 stabilizes TSC2 by inhibiting the interaction between TSC2 and the HERC1 ubiquitin ligase
  publication-title: J Biol Chem
– volume: 169
  start-page: 570
  year: 2017
  end-page: 586
  article-title: Metabolic Instruction of Immunity
  publication-title: Cell
– volume: 27
  start-page: 502
  issue: 2
  year: 2019
  end-page: 513.
  article-title: Autophagy regulation of metabolism is required for CD8(+) T cell anti‐tumor immunity
  publication-title: Cell Rep
– volume: 563
  start-page: 569
  year: 2018
  end-page: 573
  article-title: Autophagy maintains tumour growth through circulating arginine
  publication-title: Nature
– volume: 27
  start-page: 591
  year: 2009
  end-page: 619
  article-title: T cell activation
  publication-title: Annu Rev Immunol
– volume: 188
  start-page: 4721
  year: 2012
  end-page: 4729
  article-title: Mammalian target of rapamycin integrates diverse inputs to guide the outcome of antigen recognition in T cells
  publication-title: J Immunol
– volume: 5
  start-page: 976
  year: 1994
  end-page: 989
  article-title: An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database
  publication-title: J Am Soc Mass Spectrom
– volume: 35
  start-page: 63
  year: 2017
  end-page: 70
  article-title: MYC and HIF in shaping immune response and immune metabolism
  publication-title: Cytokine Growth Factor Rev
– volume: 8
  start-page: 276
  year: 2018
  end-page: 287
  article-title: Autophagy sustains pancreatic cancer growth through both cell‐autonomous and nonautonomous mechanisms
  publication-title: Cancer Discov
– volume: 4
  start-page: 648
  year: 2002
  end-page: 657
  article-title: TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
  publication-title: Nat Cell Biol
– volume: 14
  start-page: 122
  year: 2014
  end-page: 131
  article-title: The roles of Pellino E3 ubiquitin ligases in immunity
  publication-title: Nat Rev Immunol
– volume: 68
  start-page: 850
  year: 1996
  end-page: 858
  article-title: Mass spectrometric sequencing of proteins silver‐stained polyacrylamide gels
  publication-title: Anal Chem
– ident: e_1_2_9_13_1
  doi: 10.3389/fimmu.2018.00014
– ident: e_1_2_9_7_1
  doi: 10.1038/ni.2090
– volume: 161
  start-page: 5516
  year: 1998
  ident: e_1_2_9_40_1
  article-title: Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell‐tumor fusion vaccines
  publication-title: J Immunol
  doi: 10.4049/jimmunol.161.10.5516
– ident: e_1_2_9_15_1
  doi: 10.1016/j.cytogfr.2017.03.004
– ident: e_1_2_9_34_1
  doi: 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
– ident: e_1_2_9_25_1
  doi: 10.1016/j.it.2008.10.001
– ident: e_1_2_9_8_1
  doi: 10.1038/ni.1777
– ident: e_1_2_9_2_1
  doi: 10.1002/ijc.2910610120
– ident: e_1_2_9_42_1
  doi: 10.1158/2159-8290.CD-17-0952
– ident: e_1_2_9_23_1
  doi: 10.1016/j.celrep.2018.01.040
– ident: e_1_2_9_6_1
  doi: 10.1016/j.cell.2013.05.016
– ident: e_1_2_9_20_1
  doi: 10.1038/s41571-019-0203-7
– ident: e_1_2_9_9_1
  doi: 10.1038/nri3198
– ident: e_1_2_9_17_1
  doi: 10.1038/ncb839
– ident: e_1_2_9_22_1
  doi: 10.1146/annurev-immunol-032712-095956
– ident: e_1_2_9_37_1
  doi: 10.4161/auto.1.2.1697
– ident: e_1_2_9_14_1
  doi: 10.1016/1044-0305(94)80016-2
– ident: e_1_2_9_19_1
  doi: 10.1172/JCI73939
– ident: e_1_2_9_28_1
  doi: 10.1126/science.1242454
– ident: e_1_2_9_18_1
  doi: 10.1038/cmi.2011.60
– ident: e_1_2_9_39_1
  doi: 10.4049/jimmunol.1103143
– ident: e_1_2_9_41_1
  doi: 10.1016/S1097-2765(01)00187-3
– ident: e_1_2_9_5_1
  doi: 10.1016/j.cell.2017.04.004
– ident: e_1_2_9_4_1
  doi: 10.1038/sj.onc.1204009
– ident: e_1_2_9_30_1
  doi: 10.1038/s41586-018-0697-7
– ident: e_1_2_9_32_1
  doi: 10.1084/jem.20062694
– ident: e_1_2_9_45_1
  doi: 10.1038/s41590-019-0405-2
– ident: e_1_2_9_10_1
  doi: 10.1074/jbc.C500451200
– ident: e_1_2_9_27_1
  doi: 10.1002/eji.201141411
– ident: e_1_2_9_24_1
  doi: 10.1101/gad.1599207
– ident: e_1_2_9_33_1
  doi: 10.1158/1078-0432.CCR-17-0894
– ident: e_1_2_9_43_1
  doi: 10.1016/j.smim.2012.12.004
– ident: e_1_2_9_3_1
  doi: 10.1016/j.smim.2016.10.009
– ident: e_1_2_9_44_1
  doi: 10.4161/trns.28263
– ident: e_1_2_9_31_1
  doi: 10.1038/nri3701
– ident: e_1_2_9_21_1
  doi: 10.1146/annurev-cellbio-092910-154237
– ident: e_1_2_9_36_1
  doi: 10.1146/annurev.immunol.021908.132706
– ident: e_1_2_9_16_1
  doi: 10.1042/BJ20080281
– ident: e_1_2_9_26_1
  doi: 10.1038/nri3599
– ident: e_1_2_9_12_1
  doi: 10.1016/j.celrep.2019.03.037
– ident: e_1_2_9_35_1
  doi: 10.1038/nature11866
– ident: e_1_2_9_38_1
  doi: 10.1002/gene.20012
– ident: e_1_2_9_11_1
  doi: 10.1016/j.cell.2018.08.061
– ident: e_1_2_9_29_1
  doi: 10.1002/jms.229
SSID ssj0005871
Score 2.4501088
Snippet Metabolic fitness of T cells is crucial for immune responses against infections and tumorigenesis. Both the T cell receptor (TCR) signal and environmental cues...
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e104532
SubjectTerms Ablation
Animals
Antitumor activity
CD4 antigen
CD4-Positive T-Lymphocytes - metabolism
CD8 antigen
CD8-Positive T-Lymphocytes - metabolism
Cell activation
Cell Line
Cell Line, Tumor
Dimerization
Effector cells
EMBO19
EMBO21
EMBO31
Glycolysis
Glycolysis - physiology
Growth factors
HEK293 Cells
Humans
Immunity
Kinases
Lymphocytes
Lymphocytes T
Mechanistic Target of Rapamycin Complex 1 - metabolism
Metabolic rate
Metabolism
Mice
Mice, Inbred C57BL
Mice, Transgenic
mTORC1
Nuclear Proteins - metabolism
Peli1
Proteins
Receptors, Antigen, T-Cell - metabolism
Signal transduction
T cell metabolism; antitumor immunity
T cell receptors
Tuberous Sclerosis Complex 1
Tuberous Sclerosis Complex 1 Protein - metabolism
Tuberous Sclerosis Complex 2
Tuberous Sclerosis Complex 2 Protein - metabolism
Tumorigenesis
Ubiquitin
Ubiquitin-protein ligase
Ubiquitin-Protein Ligases - metabolism
Ubiquitination
Title The E3 ubiquitin ligase Peli1 regulates the metabolic actions of mTORC1 to suppress antitumor T cell responses
URI https://link.springer.com/article/10.15252/embj.2020104532
https://onlinelibrary.wiley.com/doi/abs/10.15252%2Fembj.2020104532
https://www.ncbi.nlm.nih.gov/pubmed/33215753
https://www.proquest.com/docview/2477899825
https://www.proquest.com/docview/2463099842
https://pubmed.ncbi.nlm.nih.gov/PMC7809702
Volume 40
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZQEYILouW1UCojcQEpavxK7GMbbVVVKiC0lXqLYseGoN2kbJID_56xk82yagFxjOxMYs_Y841nPIPQu1JzYYw1kVHaRRzWYqQUd1GpjFJOqliHFBuXH5PzK35xLa7H8w5_F-Z3_72ggh7blf4OZpx32nLBYLO9LwhLfZGGLMm2wRwymFbhNIUTqUaH5F0UdhXQLVR5Ozhy8pDu4teggM6eoMcjcsQnA6v30T1bH6AHQy3JnwfoYbYp3fYU1cB8PGe419WPvuqqGi-rr6Cu8Ge7rAheD_XnbYsB_eGV7UAQlpXBwx2HFjcOrxafvmQEdw1u-5sQK4sLf6G3XzVrvMD-uB_IhPBa2z5DV2fzRXYejYUVIgOAjUbKSscKykVJSiepxzhFKo2juii1jRNXalYQQxKnHaXGwU4kE1tCt1g6njD2HO3VTW1fIiyZpVpowxPtcw9STR1JE6Kd4KVjxMzQ8Wa2czNmHffFL5a5tz48f3LPn3zLnxl6P71xM2Tc-Evfww0D83HttTnlaeqtSCpm6O3UDBzwc1PUtul9n4QBNpYcSLwY-D19jDGAQWDFzVC6IwlTB5-Re7elrr6FzNypjFUaA80PG5nZ_tafxyCCVP1zsPn88vRi-_jqfz7yGj2iPhgnJhERh2ivW_f2DaCpTh-FhXTkNZr4BUC8FlE
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELemTmi8IBhfhQFG4gWkaPFXYj-WqlMp60DQSXuLYsceQW0ymuSB_x7b-aiq8SEeI18use9s_853vgPgTSYpU0qrQAlpAmrnYiAENUEmlBCGi1D6FBvLi2h-SRdX7OoA4P4ujI92712SfqXuavTgU72R361B59y3lBG77B5yFnE2AoeTyeLrYhfYwb2Z5U9WKOKic07-jsf-ZnQLYd4OlBy8pftY1m9GZ_fBvQ5Fwkkr9gfgQBfH4E5bV_LnMTia9mXcHoLCKgKcEdjI_EeT13kB1_m13brgZ73OEdy2teh1BS0ShBtdW6VY5wq29x0qWBq4WX36MkWwLmHV3Pi4WZi6y73NptzCFXRH_5aND7XV1SNweTZbTedBV2QhUBa84UBobkiKKctQZjh2eCeNuTJYppnUYWQySVKkUGSkwVgZuyrxSGeWLOSGRoQ8BqOiLPRTADnRWDKpaCRdHkIssUFxhKRhNDMEqTE47Uc7UV0GclcIY504S8TJJ3HySXbyGYO3wxs3bfaNv9Ce9AJMunlYJZjGsbMoMRuD10OzlYAbm7TQZeNoImJxMqeWxZNW3sPHCLGQyFp0YxDvacJA4LJz77cU-TefpTvmoYhDy_NdrzO73_pzH5jXqn92Npkt3y92j8_-5yOvwNF8tTxPzj9cfHwO7mIXpBOiALETMKq3jX5hUVYtX3bT6hfA4h3O
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZQEY8LgvJaaMFIXECKNn4ksY-Q7qoUWiq0lXqLYsemqXaTZZMc-PeM81qtykMcI08msWdsf-MZzyD0NlM80NpoT0tlPQ5z0ZOSWy-TWkorpK_aFBunZ-HxBT-5DC77A7dqiHYfXJLdnQaXpamop-vMDvV66NSs1DUYd86VywMGS_BtsFOIM77iMN6GeIjW4GrPWDgRsndT_o7D7rZ0A2veDJkc_aa7qLbdluYP0YMeT-IPnQI8QrdMsY_udBUmf-6je_FQ0O0xKkAl8IzhRuU_mrzOC7zMv8Mmhs_NMid401WlNxUGTIhXpgb1WOYadzcfKlxavFp8_RYTXJe4atZtBC1O3TXfZlVu8AI7JwCwaYNuTfUEXcxni_jY68steBpgHPWkEZallAcZyaygDvmkkdCWqjRTxg9tplhKNAmtspRqC-uTCE0GZL6wPGTsKdorysI8R1gwQ1WgNA-Vy0hIFbUkComyAc8sI3qCpsNoJ7rPRe5KYiwTZ5M4-SROPslWPhP0bnxj3eXh-AvtwSDApJ-RVUJ5FDnbkgYT9GZsBgm4sUkLUzaOJmSAmAUHFs86eY8fYwzAEdh2ExTtaMJI4PJ077YU-VWbrzsSvox84Pl-0Jntb_25D0GrVf_sbDI7_XiyfXzxPx95je6eH82TL5_OPr9E96mL1vGJR4IDtFdvGnMIcKtWr9o59Qv-mCCo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+E3+ubiquitin+ligase+Peli1+regulates+the+metabolic+actions+of+mTORC1+to+suppress+antitumor+T+cell+responses&rft.jtitle=The+EMBO+journal&rft.au=Ko%2C+Chun%E2%80%90Jung&rft.au=Zhang%2C+Lingyun&rft.au=Jie%2C+Zuliang&rft.au=Zhu%2C+Lele&rft.date=2021-01-15&rft.issn=0261-4189&rft.eissn=1460-2075&rft.volume=40&rft.issue=2&rft.epage=n%2Fa&rft_id=info:doi/10.15252%2Fembj.2020104532&rft.externalDBID=10.15252%252Fembj.2020104532&rft.externalDocID=EMBJ2020104532
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0261-4189&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0261-4189&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0261-4189&client=summon